Commure + PatientKeeper: Fixing Fragmentation to Accelerate Innovation Across Healthcare
Commure to Acquire PatientKeeper Commure has entered into an agreement to acquire PatientKeeper. This transaction represents the first step…
GuideWell invests in Vim to accelerate value-based care
Technology to improve data and workflow connectivity for value-based payer-provider partnerships GuideWell Mutual Holding Corporation (GuideWell), the parent to…
Intel, ConsenSys Health Advance Pandemic Research
ConsenSys Health applies privacy-preserving blockchain security, with support from Intel’s Pandemic Response Technology Initiative, to help combat COVID-19. Healthcare…
HSR.health Releases new GeoHealth Analytic Dashboard to Target and Eliminate Healthcare Inequities
Dashboard identifies the unique needs of the most vulnerable members of society HSR.health, the leading provider of health-focused geospatial…
Health Payment Systems, Inc Names Centivo Third-Party Administrator for BHCG Member Employers
Healthcare Payments Innovator Announces Partnership to Streamline Data, Care management & Stop Loss Health Payment Systems, Inc. (HPS), an innovator…
Better Than 8K Resolution: NVIDIA Inception Displays Global AI Startup Ecosystem
NVIDIA Startup Accelerator Surpasses 8,500 Members, Healthcare Leads the Pack There are more AI startups in healthcare than any…
Socially Determined Accelerates Time-to-Value for SDOH Insights and Initiatives with Enhancements to SocialScape Platform
New Capabilities from Pioneer of Social Risk Intelligence Enable Organizations to See, Understand and Act on Social Determinants of…
Orchestra BioMed Announces Clinical Data Demonstrating a Significant and Sustained Reduction in Blood Pressure in MODERATO II Control Patients After Crossover to BackBeat Cardiac Neuromodulation Therapy
Data Shows BackBeat CNT Reduces Blood Pressure in Crossover Hypertensive Patients Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”),…
Sema4 Set to Go Public via $500M SPAC deal
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company Sema4,…
Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…